The urologic oncologists at NewYork-Presbyterian Lawrence provide comprehensive diagnostic, treatment, and follow-up care for people with urologic cancers, such as prostate cancer, bladder cancer, and kidney cancer. You can receive all the care you need in one location, including cancer surgery (performed whenever possible using minimally invasive approaches such as robotic surgery); chemotherapy and immunotherapy in our modern and comfortable infusion center; advanced radiation therapy; and survivorship services.
A Team Approach
Our dedicated staff includes urologic surgeons, medical and radiation oncologists, pathologists, radiologists, oncology nurses, radiation therapists, and a support team with experience caring for people with urologic cancers. The team gathers at regular Tumor Board meetings to discuss each case and combine their expertise to assemble the most effective treatment plan for each patient.
Care for All Stages of Prostate Cancer
We perform image-guided biopsy techniques to make an accurate diagnosis of prostate cancer. If you learn you have prostate cancer, we employ MRI scanning and molecular biomarker analysis to help you make an informed decision about whether you need treatment. You may need surgery, chemotherapy, radiation therapy, hormonal therapy, a combination of these treatments—or none at all, with periodic monitoring (active surveillance). We manage the care of men with all stages of prostate cancer and assemble the team of doctors that you need. Learn more.
Advanced Bladder Cancer Treatment
Our urologic oncology team aims to preserve your bladder whenever possible while providing the most effective therapies. We have surgical expertise in complex bladder reconstruction when bladder preservation isn't appropriate. We perform both robotic and "open" surgery, deliver intravesical therapies (anticancer drugs applied directly into the bladder), and conduct clinical trials of new treatments to reduce your risk of cancer recurrence. Our goal is to destroy the tumor while preserving your quality of life as much as we can. Learn more.
The Latest Kidney Cancer Treatments
NewYork-Presbyterian Lawrence provides comprehensive care for people with kidney cancer, including renal cell carcinoma and transitional cell carcinoma. We offer:
- Minimally invasive surgery. If you are a candidate for kidney cancer surgery, you will have either your entire kidney removed (radical nephrectomy) or just the part of it containing your tumor (partial nephrectomy). We have developed minimally invasive kidney surgery techniques, including robotic nephrectomy, enabling us to remove the tumor while preserving as much of the affected kidney—and its function—as possible. Your surgeon will let you know what options are available to you. Some people with small kidney tumors can undergo regular monitoring instead of surgery or other treatments.
- Precision therapies. Many people with kidney cancer benefit from "focal" therapies that are directed right to the tumor to kill cancer cells while sparing nearby healthy tissue. We treat some kidney cancers using freezing temperatures (cryosurgery) or extreme heat (radioablation) applied through a needle into the tumor; focused ultrasound (the application of high-energy sound waves); and radiation therapy.
- Oral anticancer drugs such as cabozantinib, lenvatinib, sunitinib, sorafenib, and pazopanib are options for many patients with renal cell cancers.
- Immunotherapy, such as nivolumab, is given in our infusion center and harnesses the power of the immune system to find and destroy kidney cancer cells.
Other Urologic Cancers
Our team is also experienced in the diagnosis and treatment of other urologic cancers, such as testis and penile cancer, offering comprehensive care for all stages of these diseases.
We understand how a diagnosis of a urologic cancer can affect your life and the lives of your loved ones. Therefore, your team includes other healthcare professionals you may need for the treatment of symptoms, as well as psychosocial support, rehabilitation, and nutrition during and after urologic cancer therapy.
Planning for Your Future
Cancer care does not end with treatment, so NewYork-Presbyterian Lawrence has established a Cancer Survivorship Clinical Program. Our survivorship team will serve as a bridge between your oncology and primary care teams by providing a survivorship care plan—a roadmap for your future health care. We also work closely with other NewYork-Presbyterian specialists in gynecology, cardiology, bone health, and rehabilitation and physical therapy to address your other medical needs. We offer a monthly support group for cancer survivors, with special programming and events throughout the year.
A Commitment to Research
Our doctors and laboratory scientists at Columbia University Medical Center are working together to study how urologic cancers grow and develop, with the aim of developing better therapies. Because of our collaboration with the National Cancer Institute (NCI)-designated Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian/Columbia — one of only 47 NCI-designated centers in the country — we may be able to connect you with a clinical trial of a promising new therapy.